Tag: Eculizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eculizumab

CDSCO approves AstraZeneca's anti-complement medicine Eculizumab - Express Pharma

Added to Collection on: 2025-01-17 16:04:40

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Rare diseases
Hematology
Atypical hemolytic uremic syndrome
Syndromes
Hemolytic–uremic syndrome
Hemolysis
Eculizumab
Thrombotic microangiopathy
Paroxysmal nocturnal hemoglobinuria
Ahus
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details
UPC Court of Appeal confirms strict approach to correcting patent errors by interpretation

Added to Collection on: 2025-02-04 18:53:51

Tags for this article:

European Patent Organisation
Patent law
European Patent Convention
Prior art
United States patent law
Eculizumab
Person having ordinary skill in the art
Patent claim
Amendments under the European Patent Convention
Kirin-Amgen Inc v Hoechst Marion Roussel Ltd

Click the tags to see associated articles and topics

View Article Details
Delaware Supreme Court reverses trial court for failing to apply "Interrelated Wrongful Acts ...

Added to Collection on: 2025-02-07 16:14:27

Tags for this article:

Types of insurance
Specialty drugs
Alexion Pharmaceuticals
AstraZeneca
Directors and officers liability insurance
Securities Act
Eculizumab
Class action
Securities Class Action
Liability insurance
SEC Rule 10b-5
United States Securities Regulation

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Market Expected to rise, - openPR.com

Added to Collection on: 2025-02-06 20:07:40

Tags for this article:

Blood disorders
Rare diseases
Acquired hemolytic anemia
Monoclonal antibodies
Kidney diseases
Atypical hemolytic uremic syndrome
Ahus
Hemolytic–uremic syndrome
Alexion Pharmaceuticals
Hemolysis
Eculizumab
Complement factor I
United States

Click the tags to see associated articles and topics

View Article Details
Iptacopan Is a Cost-Effective Therapy in Improving Quality of Life in PNH

Added to Collection on: 2025-02-21 20:21:55

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Health care quality
Paroxysmal nocturnal hemoglobinuria
Quality-adjusted life year
Iptacopan
Eculizumab
Ravulizumab
Danicopan

Click the tags to see associated articles and topics

View Article Details
Samsung Bioepis (CEO Kim Kyung-ah) announced on the 8th that it has launched its rare ...

Added to Collection on: 2025-04-08 01:44:30

Tags for this article:

Blood disorders
Monoclonal antibodies
Immunosuppressants
Specialty drugs
Orphan drugs
Eculizumab
Samsung Biologics
Atypical hemolytic uremic syndrome
Samsung
Hemolytic–uremic syndrome
Teva Pharmaceuticals
Biosimilar
samsung bioepis
United States
Teva

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Market Expected Rise, 2034 | - openPR.com

Added to Collection on: 2025-04-27 20:43:43

Tags for this article:

Blood disorders
Rare diseases
Monoclonal antibodies
Acquired hemolytic anemia
Hematopathology
Atypical hemolytic uremic syndrome
Ahus
Hemolytic–uremic syndrome
Alexion Pharmaceuticals
Hemolysis
Eculizumab
Crovalimab
United States

Click the tags to see associated articles and topics

View Article Details
Biosimilar Monoclonal Antibodies Market Know the Scope and Trends - openPR.com

Added to Collection on: 2025-05-16 14:59:59

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Immunology
Biosimilar
Adalimumab
Biopharmaceutical
Infliximab
Rituximab
Trastuzumab
Bevacizumab
Denosumab
Cetuximab
Ranibizumab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Future Outlook of the Soliris Intravenous Market - openPR.com

Added to Collection on: 2025-05-20 17:25:20

Tags for this article:

Rare diseases
Monoclonal antibodies
Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Atypical hemolytic uremic syndrome
Ahus
Hemolysis
Paroxysmal nocturnal hemoglobinuria

Click the tags to see associated articles and topics

View Article Details
Alexion awarded injunction against Amgen in SOLIRIS patent action - JD Supra

Added to Collection on: 2025-05-27 19:05:19

Tags for this article:

Patent law
Immunosuppressants
Orphan drugs
Monoclonal antibodies
Eculizumab
Rare diseases
Alexion Pharmaceuticals
Novelty
Paroxysmal nocturnal hemoglobinuria
Biosimilar
Amgen
PNH
Amgen Canada Inc
Alexion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo